These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 12916910)
1. Preparation and characterization of poly(D,L-lactide-co-glycolide) microspheres for controlled release of human growth hormone. Capan Y; Jiang G; Giovagnoli S; Na KH; DeLuca PP AAPS PharmSciTech; 2003; 4(2):E28. PubMed ID: 12916910 [TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery. Woo BH; Jiang G; Jo YW; DeLuca PP Pharm Res; 2001 Nov; 18(11):1600-6. PubMed ID: 11758769 [TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres. Jiang G; Qiu W; DeLuca PP Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968 [TBL] [Abstract][Full Text] [Related]
4. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method. Kang J; Wu F; Cai Y; Xu M; He M; Yuan W Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681 [TBL] [Abstract][Full Text] [Related]
5. Preparation and in vivo evaluation of PCADK/PLGA microspheres for improving stability and efficacy of rhGH. Wang C; Yu C; Liu J; Teng L; Sun F; Li Y Int J Pharm; 2015 Nov; 495(2):924-31. PubMed ID: 26456269 [TBL] [Abstract][Full Text] [Related]
6. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis. Duvvuri S; Janoria KG; Pal D; Mitra AK J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010 [TBL] [Abstract][Full Text] [Related]
7. Use of infrared spectroscopy to assess secondary structure of human growth hormone within biodegradable microspheres. Yang TH; Dong A; Meyer J; Johnson OL; Cleland JL; Carpenter JF J Pharm Sci; 1999 Feb; 88(2):161-5. PubMed ID: 9950632 [TBL] [Abstract][Full Text] [Related]
8. A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles. Wei Y; Wang Y; Kang A; Wang W; Ho SV; Gao J; Ma G; Su Z Mol Pharm; 2012 Jul; 9(7):2039-48. PubMed ID: 22663348 [TBL] [Abstract][Full Text] [Related]
9. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization. Xu H; Zhong H; Liu M; Xu C; Gao Y Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119 [TBL] [Abstract][Full Text] [Related]
10. Raloxifene-/raloxifene-poly(ethylene glycol) conjugate-loaded microspheres: A novel strategy for drug delivery to bone forming cells. Kavas A; Keskin D; Altunbaş K; Tezcaner A Int J Pharm; 2016 Aug; 510(1):168-83. PubMed ID: 27343363 [TBL] [Abstract][Full Text] [Related]
11. Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release. Kim HK; Park TG J Control Release; 2004 Jul; 98(1):115-25. PubMed ID: 15245894 [TBL] [Abstract][Full Text] [Related]
12. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications. Ma G J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676 [TBL] [Abstract][Full Text] [Related]
13. Microsphere delivery of Risperidone as an alternative to combination therapy. D'Souza S; Faraj J; DeLuca P Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159 [TBL] [Abstract][Full Text] [Related]
14. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation. Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594 [TBL] [Abstract][Full Text] [Related]
15. Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism. Kim HK; Park TG Biotechnol Bioeng; 1999 Dec; 65(6):659-67. PubMed ID: 10550772 [TBL] [Abstract][Full Text] [Related]
16. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone. Kim HK; Chung HJ; Park TG J Control Release; 2006 May; 112(2):167-74. PubMed ID: 16542746 [TBL] [Abstract][Full Text] [Related]
18. Preparation and physicochemical characterization of T-OA PLGA microspheres. Fu J; Dong XX; Zeng ZP; Yin XB; Li FW; Ni J Chin J Nat Med; 2017 Dec; 15(12):912-916. PubMed ID: 29329648 [TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique. Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445 [TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro study of hydrochloric norvancomycin encapsulated poly (d,l-lactide-co-glycolide, PLGA) microspheres for potential use in osteomyelitis. Yang H; Hao Y; Liu Q; Mi Z; Wang Z; Zhu L; Feng Q; Hu N Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1326-1330. PubMed ID: 27776425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]